SILO PHARMA, INC. (SILO) Operating margin 2019–2025
SILO PHARMA, INC. (SILO) operating margin by fiscal year — reported operating income divided by reported revenue.
-5937.0%FY2025 · since FY2019: -2293.4% → -5937.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -5937.0% | +589.5 pp |
| FY2024 | -6526.4% | -1179.0 pp |
| FY2023 | -5347.4% | -316.1 pp |
| FY2022 | -5031.3% | — |
| FY2020 | -5380.2% | -3086.8 pp |
| FY2019 | -2293.4% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More SILO financial trends
SILO RevenueSILO Net incomeSILO Net marginSILO Gross profitSILO Gross marginSILO Operating incomeSILO Operating cash flowSILO Free cash flowSILO Capital expendituresSILO Return on equitySILO Stock buybacksSILO Dividends paidSILO Total assetsSILO Total liabilitiesSILO Shareholders’ equitySILO overview →